BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,800 | -59.8% | 49,999 | 0.0% | 0.00% | -50.0% |
Q2 2023 | $6,967 | +63.9% | 49,999 | 0.0% | 0.00% | +100.0% |
Q1 2023 | $4,250 | +84.5% | 49,999 | 0.0% | 0.00% | – |
Q4 2022 | $2,303 | -67.1% | 49,999 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $7,000 | 0.0% | 49,999 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $7,000 | – | 49,999 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 369,289 | $3,774,134 | 0.21% |
Radcliffe Capital Management, L.P. | 200,049 | $2,052,503 | 0.06% |
LMR Partners LLP | 125,000 | $1,277,500 | 0.02% |
Q Global Advisors, LLC | 195,489 | $20 | 0.01% |
MARSHALL WACE, LLP | 190,150 | $1,954,743 | 0.00% |
MMCAP International Inc. SPC | 325,000 | $32,468 | 0.00% |
COWEN AND COMPANY, LLC | 177,845 | $17,766 | 0.00% |
PERISCOPE CAPITAL INC. | 867,072 | $37,140 | 0.00% |
CLEAR STREET LLC | 712,660 | $71 | 0.00% |
CANTOR FITZGERALD, L. P. | 250,000 | $25 | 0.00% |